Clinical trial
Efficacy and Safety Study of Diclofenac HPBCD 25, 50 mg/ml Administered as Single s.c. Dose, in the Treatment of Acute Moderate-to-severe Post-surgical Pain From Dental Surgery (Impacted 3rd Molar Extraction)
NCT00942448 is registered in ClinicalTrials.gov with IBSA Institut Biochimique SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety Study of Diclofenac HPBCD 25, 50 mg/ml Administered as Single s.c. Dose, in the Treatment of Acute Moderate-to-severe Post-surgical Pain From Dental Surgery (Impacted 3rd Molar Extraction)
- Lead sponsor
- IBSA Institut Biochimique SA
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- April 30, 2010
- Enrollment
- 306 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
dental pain